Why the study?
Is plasma alpha-hANP concentration useful for determining dry weight and assessing cardiac complications in hemodialysis patients?
Is plasma alpha-hANP concentration useful for determining dry weight and assessing cardiac complications in hemodialysis patients?
Plasma alpha-hANP is a useful biomarker for determining dry weight and identifying cardiac complications like atrial fibrillation in hemodialysis patients.
Post-dialysis alpha-hANP ≤70 pg/ml may guide dry weight assessment; cross-sectional data leave open prospective validation in AF and mitral regurgitation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yuasa et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: